ES8802144A1 - Un procedimiento para la preparacion de derivados de fenotiazinas. - Google Patents
Un procedimiento para la preparacion de derivados de fenotiazinas.Info
- Publication number
- ES8802144A1 ES8802144A1 ES536525A ES536525A ES8802144A1 ES 8802144 A1 ES8802144 A1 ES 8802144A1 ES 536525 A ES536525 A ES 536525A ES 536525 A ES536525 A ES 536525A ES 8802144 A1 ES8802144 A1 ES 8802144A1
- Authority
- ES
- Spain
- Prior art keywords
- 6alkyl
- phenyl
- hydrogen
- substituted
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/38—[b, e]-condensed with two six-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
- C07D279/20—[b, e]-condensed with two six-membered rings with hydrogen atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
- C07D279/22—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
- C07D279/22—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
- C07D279/30—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom with acyl radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
- C07D279/34—[b, e]-condensed with two six-membered rings with hetero atoms directly attached to the ring sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D293/00—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
- C07D293/10—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms condensed with carbocyclic rings or ring systems
Abstract
UN PROCEDIMIENTO PARA LA PREPARACION DE DERIVADOS DE FENOTIAZINAS. LAS FENOTIAZINAS (I), DONDE NO EXHAUSTIVAMENTE, R1 ES H O CH3, R2 ES H O 2-OME, R3 ES 4-X CON X F CL O BR, R4 ES H, 7-F O 7-OME, R ES H Y T ES 3-OH; SE PREPARAN POR A) REACCION DE UNA BENZOQUINONA (II) CON UN 2-AMINOBENZOL (III), EN UN DISOLVENTE ADECUADO, TIPO METANOL, EN UN INTERVALO ENTRE C20 Y 60JC, DESPUES B) SE HALOGENA EN PRESENCIA DE UN ACIDO ALCANOICO, COMO EL ACETICO; TRAS LO CUAL C) SE REDUCE, DENTRO DE DISOLVENTE ADECUADO, ENTRE 10 Y 50JC PARA DESPUES; D) HACER REACCIONAR CON ANHIDRIDO, E) CON HALURO DE ALQUILO O ACILO Y FINALMENTE F) HIDROLIZAR CON UNA BASE. COMO INHIBIDORES DE LA BIOSINTESIS DE LEUCOTRIENOS EN MAMIFEROS, SON AGENTES TERAPEUTICOS UTILES EN EL TRATAMIENTO DE LAS CONDICIONES ALERGICAS, ASMA, TRASTORNOS CARDIOVASCULARES E INFLAMACIONES, Y COMO AGENTES CITOPROTECTORES.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53934283A | 1983-10-05 | 1983-10-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8802144A1 true ES8802144A1 (es) | 1988-04-01 |
ES536525A0 ES536525A0 (es) | 1988-04-01 |
Family
ID=24150810
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES536525A Expired ES8802144A1 (es) | 1983-10-05 | 1984-10-04 | Un procedimiento para la preparacion de derivados de fenotiazinas. |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0138481B1 (es) |
JP (1) | JPS60155165A (es) |
CA (1) | CA1272722A (es) |
DE (1) | DE3484745D1 (es) |
DK (1) | DK475684A (es) |
ES (1) | ES8802144A1 (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1309557C (en) | 1985-06-18 | 1992-10-27 | Robert N. Young | Leukotriene antagonists |
DE3526566A1 (de) * | 1985-07-25 | 1987-02-05 | Boehringer Mannheim Gmbh | N-acyl-dihydroresorufin-derivate, verfahren zu deren herstellung sowie deren verwendung zur bestimmung von wasserstoffperoxid, peroxidatisch wirkender verbindungen oder peroxidase |
EP0239306B1 (en) | 1986-03-27 | 1993-06-02 | Merck Frosst Canada Inc. | Tetrahydrocarbazole esters |
US4707473A (en) * | 1986-05-30 | 1987-11-17 | Syntex (U.S.A.) Inc. | 4-monosubstituted and 4,6-disubstituted phenoxazines |
US4803269A (en) * | 1986-05-30 | 1989-02-07 | Syntex (U.S.A.) Inc. | 4-monosubstituted and 4,6-disubstituted N-(α-phenylethyl)phenoxazines |
CA2053216C (en) | 1990-10-12 | 2003-04-08 | Michel L. Belley | Saturated hydroxyalkylquinoline acids as leukotriene antagonists |
US5410054A (en) * | 1993-07-20 | 1995-04-25 | Merck Frosst Canada, Inc. | Heteroaryl quinolines as inhibitors of leukotriene biosynthesis |
US6333322B1 (en) | 1996-03-13 | 2001-12-25 | Eisai Co., Ltd. | Nitrogen-containing tricyclic compounds and drugs containing the same |
EP1057830A4 (en) * | 1998-02-27 | 2001-09-19 | Eisai Co Ltd | HETEROCYCLIC CONDENSED BENZOTHIAZINE DERIVATIVES |
CA2310205A1 (en) * | 2000-05-29 | 2001-11-29 | Dalhousie University | Unknown |
US6818787B2 (en) | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US7186855B2 (en) | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US7232924B2 (en) | 2001-06-11 | 2007-06-19 | Xenoport, Inc. | Methods for synthesis of acyloxyalkyl derivatives of GABA analogs |
NZ567711A (en) * | 2001-06-11 | 2009-10-30 | Xenoport Inc | Orally administered dosage forms of GABA analog prodrugs having reduced toxicity |
US7432372B2 (en) | 2003-10-31 | 2008-10-07 | Invitrogen Corporation | Fluorinated resorufin compounds and their application |
KR101228399B1 (ko) | 2004-11-04 | 2013-01-31 | 제노포트 인코포레이티드 | 가바펜틴 프로드러그 서방성 경구 투여 형태 |
WO2011093443A1 (ja) * | 2010-01-29 | 2011-08-04 | 日本ゼオン株式会社 | 縮合複素環化合物及び組成物 |
US8609753B2 (en) * | 2010-01-29 | 2013-12-17 | Zeon Corporation | Acrylic rubber composition and cross-linked rubber product |
TW201236239A (en) * | 2010-11-16 | 2012-09-01 | Solvay | Rechargeable metal or metal-ion cell |
EP3473254B1 (en) * | 2011-08-02 | 2024-01-24 | Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH | Phenothiazine derivatives for the treatment of autoimmune diseases |
US9296712B2 (en) | 2013-03-15 | 2016-03-29 | Edison Pharmaceuticals, Inc. | Resorufin derivatives for treatment of oxidative stress disorders |
US9868711B2 (en) | 2013-03-15 | 2018-01-16 | Bioelectron Technology Corporation | Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders |
US9670170B2 (en) | 2013-03-15 | 2017-06-06 | Bioelectron Technology Corporation | Resorufin derivatives for treatment of oxidative stress disorders |
CN114213359B (zh) * | 2022-01-12 | 2023-07-25 | 郑州大学 | 一种合成1-羟基吩噻嗪类化合物的方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58225093A (ja) * | 1982-06-25 | 1983-12-27 | Kanegafuchi Chem Ind Co Ltd | ベンゾチアジノリフアマイシン誘導体およびその製造法 |
DE3229122A1 (de) * | 1982-08-04 | 1984-02-09 | Bayer Ag, 5090 Leverkusen | Anellierte 4h-1,4-benzothiazine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
NZ206795A (en) * | 1983-01-21 | 1987-08-31 | Merck Frosst Canada Inc | Phenothiazines, analogues and pharmaceutical compositions |
DE3479397D1 (en) * | 1983-10-05 | 1989-09-21 | Merck Frosst Canada Inc | Benzoûa¨phenothiazines and hydro-derivatives and pharmaceutical compositions containing them |
-
1984
- 1984-09-28 EP EP84306639A patent/EP0138481B1/en not_active Expired - Lifetime
- 1984-09-28 DE DE8484306639T patent/DE3484745D1/de not_active Expired - Lifetime
- 1984-10-04 ES ES536525A patent/ES8802144A1/es not_active Expired
- 1984-10-04 CA CA000464754A patent/CA1272722A/en not_active Expired - Lifetime
- 1984-10-04 DK DK475684A patent/DK475684A/da not_active Application Discontinuation
- 1984-10-05 JP JP59208402A patent/JPS60155165A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DE3484745D1 (de) | 1991-08-01 |
EP0138481A3 (en) | 1987-04-01 |
JPS60155165A (ja) | 1985-08-15 |
DK475684D0 (da) | 1984-10-04 |
CA1272722A (en) | 1990-08-14 |
EP0138481B1 (en) | 1991-06-26 |
ES536525A0 (es) | 1988-04-01 |
EP0138481A2 (en) | 1985-04-24 |
DK475684A (da) | 1985-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8802144A1 (es) | Un procedimiento para la preparacion de derivados de fenotiazinas. | |
KR100225299B1 (ko) | 펜탄산 유도체 | |
OA08182A (fr) | Nouveaux dérivés peptidiques à structure polycyclique azotée, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. | |
MX9102734A (es) | Derivados de n-acil-2,3-benzodiazepina, procedimiento para su preparacion y composicion farmaceutica que los contiene | |
DK0787489T3 (da) | Sammensætning, der indeholder propionyl-L-carnitin og hydroxycitronsyre eller pantothensyre | |
KR920018011A (ko) | N-아실-α-아미노산 유도체 | |
DK1484059T3 (da) | Antivirale sammensætninger, der omfatter phenyleddikesyre derivater | |
ES8607256A1 (es) | Un procedimiento para la preparacion de fenotiazonas halogenadas. | |
DE3888778T2 (de) | Polyamin-Derivate als antineoplastische Wirkstoffe. | |
FR2422405A1 (fr) | Nouveaux medicaments constitues de derives de l'acide p-aminobenzoique | |
FR2381776A1 (fr) | Procede de preparation de derives d'acide oxazolinoazetidinylbutyrique et nouveaux produits ainsi obtenus | |
ES8707208A1 (es) | Un procedimiento para la preparacion de derivados de benzo(a)fenotiazinas y benzo (a) fenoxazinas. | |
FR2623504B1 (fr) | Nouveaux derives n-(vinblastinoyl-23) d'acide amino-1 methylphosphonique, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent | |
KR890001969A (ko) | 황화합물, 이들의 제법 및 이들을 함유하는 제약학적 조성물 | |
FR2691149B1 (fr) | Nouveaux composes thiochromaniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. | |
IL90179A0 (en) | Glutamic acid derivatives,their preparation and pharmaceutical compositions containing them | |
NZ222261A (en) | Pharmaceutical compositions containing antiinflammatory drugs and cyclopentyl ethers | |
IT1205640B (it) | Nuovi composti ad attivita' antiinfiammatoria,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono | |
EP0149583B1 (en) | 3-alcoxy-2-(n-pyrrolidino)-n-pyridyl-n-furyl(or thienyl)-methyl propyl amines, their preparation and pharmaceutical compositions containing them | |
DK416289A (da) | Estere af 3-demethylthiocolchicin og n-acylanaloger | |
IT1212722B (it) | Derivato dell'acido benzoico. | |
AU2742288A (en) | Novel compound effective as cerebral insufficiency improver | |
OA09299A (fr) | Nouveaux dérivés N- (vincristinoyl-23) et N- (noranhydro-5' vinblastinoyl-23) d'acide animo-1 méthylphosphonique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. | |
PT86422A (fr) | Procede de preparation de derives d:acide dibenzo]be"-oxepine-acetique et de compositions pharmaceutiques les contenant | |
FR2422618A1 (fr) | Derives de bicycloheptane et compositions pharmaceutiques les contenant |